pillbase.ru

Myqorzo

Active substance: aficamten

aficamten

Centralised EU authorisationActive

Marketing holder: Cytokinetics (Ireland) Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • MYQORZO
    TABLET, FILM COATED · AFICAMTEN 15 mg/1
    82112-115
    Cytokinetics Inc.
  • MYQORZO
    TABLET, FILM COATED · AFICAMTEN 20 mg/1
    82112-120
    Cytokinetics Inc.
  • MYQORZO
    TABLET, FILM COATED · AFICAMTEN 5 mg/1
    82112-105
    Cytokinetics Inc.
  • MYQORZO
    TABLET, FILM COATED · AFICAMTEN 10 mg/1
    82112-110
    Cytokinetics Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3698-7307-99d9-24cdc5abd5a5,01a1208f-2dfa-75c2-b856-431d2bd45d2a,01a12091-1335-7116-8aa0-e86a67bc366a,01a12097-7a6a-7a59-8dd7-4faaf14520db;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006228
Registration status
Active
Sources
  • product · EMA · EMEA/H/C/006228 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006228 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006228 · Verified 2026-10-09